Stephen Squinto, PhD
Dr. Squinto has over 25 years of biotechnology industry experience and has received numerous honors and awards from academic and professional organizations for his scientific work. Dr. Squinto received his BA in Chemistry and PhD in Biochemistry and Biophysics from Loyola University of Chicago. Dr. Squinto was a co-founder of Alexion Pharmaceuticals, Inc. and recently served as its Executive Vice President and Chief Global Operations Officer. Prior to 2013 he was Alexion’s Global Head of Research and Development. From 1988 to 1992, Dr. Squinto held various positions at Regeneron Pharmaceuticals, Inc. Prior to Regeneron, he held a joint academic position at both the Tulane University and LSU Medical Schools. Since 2015, Dr. Squinto has been a venture partner at Orbimed, where he serves as a board member of a number of portfolio companies in the life sciences space.